GLP-1s: Approval and Clinical Concerns

GLP-1s work by _____ satiety and insulin secretion and _____ GI motility

• decreasing, decreasing

• increasing, increasing

• increasing, decreasing

• decreasing, increasing

GLP-1s are currently approved for

• Type 1 diabetes

• Weight loss

• Cardiovascular protection

• Obstructive sleep apnea

Which of the following GLP-1s recently got approved for obstructive sleep apnea?

• Semaglutide

• Dulaglutide

• Liraglutide

• Tirzepatide

A clinical concern of GLP-1s is that GLP-1s can cause loss of _____ and if stopped, can result in gain of _____

• fat, fat

• fat, muscle

• muscle, fat

• bone, fat

The obesity rate in adolescents has ______ in the last 30 years.

• Stayed the same

• Tripled

• Quadrupled

• Quintupled

True or false: GLP-1s have led the focus of healthcare to shift from management to prevention

• False

• True

What is the brand name of the GLP-1 that was first approved for weight loss?